Michael Chen

Title: Michael Chen: Innovator in Cancer Treatment

Introduction

Michael Chen is a prominent inventor based in Hsinchu County, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods.

Latest Patents

Michael Chen holds a patent for "Antigen-specific T cells and uses thereof." This patent outlines methods for inducing differentiation and proliferation of T cells. The process involves cultivating peripheral blood mononuclear cells (PBMCs) isolated from a subject with bi-specific antibodies (BsAbs) in a culture medium. This method results in T cells that possess both an anti-tumor antigen moiety and an anti-CD3 moiety on their surface. Additionally, the patent provides methods and pharmaceutical kits aimed at treating subjects suffering from cancers.

Career Highlights

Michael Chen is associated with Cytoarm Co., Ltd., where he continues to advance his research in immunotherapy. His work focuses on developing innovative solutions for cancer treatment, leveraging his expertise in T cell differentiation and proliferation.

Collaborations

Michael collaborates with talented individuals such as Kuo-Hsiang Chuang and Yi-Jou Chen, who contribute to the research and development efforts at Cytoarm Co., Ltd.

Conclusion

Michael Chen's innovative work in the field of cancer treatment exemplifies the potential of targeted therapies in improving patient outcomes. His contributions through his patent and collaboration with colleagues highlight the importance of continued research in this critical area of medicine.